ZenTech, DIA­source Im­munoAs­says ink mile­stone agree­ment

BioSpectrum (Asia) - - Supplier News -

ZenTech, a Bel­gian biotech com­pany spe­cial­ized in the de­vel­op­ment, pro­duc­tion and com­mer­cial­iza­tion of so­lu­tions for clin­i­cal di­ag­nos­tics of early life stage dis­eases and new­born screen­ing, and DIA­source Im­munoAs­says, a lead­ing di­ag­nos­tics com­pany de­liv­er­ing man­ual RIA and ELISA kits and open au­to­ma­tion so­lu­tions to in­ter­na­tional mar­kets, have an­nounced a strate­gic agree­ment, un­der which ZenTech will trans­fer its port­fo­lio of RIA prod­ucts to DIA­source, se­cur­ing the con­tin­ued pro­duc­tion and sales of these prod­ucts. ZenTech has strate­gi­cally re­ori­ented it­self to fo­cus on new­born screen­ing and early life stage dis­eases. DIA­source is the sec­ond largest sup­plier of ra­dioim­muno as says in the world, com­mit­ted to ser­vic­ing cus­tomers world­wide that use man­ual ELISA and RIA as­says and open au­to­ma­tion to com­ple­ment their port­fo­lio on closed au­to­mated sys­tems. ZenTech has a broad port­fo­lio of prod­ucts in pre­na­tal, neona­tal and pe­di­atric screen­ing and of­fers com­plete and flex­i­ble so­lu­tions to set up the screen­ing ac­tiv­ity. The com­pany ex­ports more than 95 per cent of its pro­duc­tion, es­pe­cially to Mid­dle East and South East Asia, China, South Amer­ica and Africa.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.